> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hemogenyx Responds to Clinical Hold
- URL: https://www.fdaweb.com/hemogenyx-responds-to-clinical-hold/
- Published: 2024-01-16T12:00:00.000Z
- Updated: 2026-09-14T14:20:26.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156138

Hemogenyx Pharmaceuticals says it has submitted a complete response to the FDA clinical hold on the company’s IND for HEMO-CAR-T. A company [statement](https://hemogenyx.com/announcements-and-media-coverage?ref=fdaweb.com) says the complete response is necessary before it can obtain agency consent to start Phase 1 trials of HEMO-CAR-T in acute myeloid leukemia.